Drugs Information: Goserelin
Basic Information
|
||
ID | DDInter839 | |
Drug Type | small molecule | |
Molecular Formula | C59H84N18O14 | |
Molecular Weight | - | |
Description | Goserelin is a synthetic analog of luteinizing hormone-releasing hormone used to treat breast cancer and prostate cancer by reducing secretion of gonadotropins from the pituitary. | |
ATC Classification | L02AE03 | |
IUPAC Name | (2S)-1-[(2S)-2-[(2S)-2-[(2R)-3-(Tert-Butoxy)-2-[(2S)-2-[(2S)-3-Hydroxy-2-[(2S)-2-[(2S)-3-(1H-Imidazol-5-Yl)-2-{[(2S)-5-Oxopyrrol | |
InChI | Inchi=1S/C59H84N18O14/C1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38/H6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90)/T38-,39-,40-,41-,42-,43-,44-,45+,46-/M0/S1 | |
InChI Key | BLCLNMBMMGCOAS-URPVMXJPSA-N | |
Canonical SMILES | CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O | |
Useful Links | DrugBank ChEMBL PubChem |
Interactions with Goserelin
Severity level | ID | Name | Mechanism | Detail |
---|